Table 1 Patient demographic, comorbidity, complication, medication use, and severity scoring in patients with and without acute kidney injury
Variable | Total (n = 4213) | AKI (n = 950) | Non-AKI (n = 3263) | P value |
|---|---|---|---|---|
Demographic | ||||
Age (years) | 75 (62–83) | 82 (74–87) | 72 (59–82) | < 0.001 |
Men (%) | 2557 (60.7) | 655 (68.9) | 1902 (58.3) | < 0.001 |
Comorbidity, n (%) | ||||
COPD | 479 (11.4) | 129 (13.6) | 350 (10.7) | 0.015 |
Chronic cor pulmonale | 148 (3.5) | 33 (3.5) | 115 (3.5) | 0.940 |
Pulmonary arterial hypertension | 128 (3.0) | 37 (3.9) | 91 (2.8) | 0.081 |
Hypertension | 2091 (49.6) | 602 (63.4) | 1489 (45.6) | < 0.001 |
Atrial fibrillation | 485 (11.5) | 180 (18.9) | 305 (9.3) | < 0.001 |
Cardiac dysfunction | 930 (22.1) | 372 (39.2) | 558 (17.1) | < 0.001 |
Diabetes | 829 (19.7) | 261 (27.5) | 568 (17.4) | < 0.001 |
Chronic kidney disease | 280 (6.6) | 167 (17.6) | 113 (3.5) | < 0.001 |
Cerebrovascular disease | 1333 (31.6) | 421 (44.3) | 912 (27.9) | < 0.001 |
Cancer | 376 (8.9) | 93 (9.8) | 283 (8.7) | 0.288 |
Rheumatic diseases | 117 (2.8) | 29 (3.1) | 88 (2.7) | 0.557 |
Complication, n (%) | ||||
Acute respiratory failure | 705 (16.7) | 337 (35.5) | 368 (11.3) | < 0.001 |
Medication Use, n (%) | ||||
Statin | 777 (18.4) | 234 (24.6) | 543 (16.6) | < 0.001 |
ARB | 585 (13.9) | 161 (16.9) | 424 (13.0) | 0.002 |
Diuretic | 1671 (39.7) | 711 (74.8) | 960 (29.4) | < 0.001 |
Vasoactive drugs | 527 (12.5) | 306 (32.2) | 221 (6.8) | < 0.001 |
Severity scoring | ||||
CURB-65 | 1 (1–2) | 2 (2–3) | 1 (0–1) | < 0.001 |